Literature DB >> 6791238

Quantification of tremor in rats induced by physostigmine.

P Gothóni, M Lehtinen, L Silen.   

Abstract

A simple and accurate device for recording tremor intensity in unanaesthetized and unrestrained rats is described. The physical measures of tremor are shown to have several advantages over previous devices. First, the new apparatus, unlike some earlier ones, does not restrict the animal's movements to an unusually small cage, with weighty mechanical devices or with electrical leads. Second, most earlier methods for measuring tremor use a subjective rating scale. However, the present method uses objective and reliable measures. In a double-blind, illustrative experiment involving complete crossover, Wistar rats were randomly injected IP with physostigmine in doses of 0.2, 0.4, 0.6 and 0.8 mg/kg or the corresponding amount of 0.9% NaCl solution as control. The recorded tremor intensity showed a clear dose-response relationship for physostigmine. Moreover, linear regression of the dose-response relationship showed that tremor intensity increased linearly with increasing doses of physostigmine. The cholinergic antagonist atropine (0.3 mg/kg SC) antagonized physostigmine-induced tremor, whereas methylatropine (0.3 mg/kg SC) tended to potentiate it. These results show that the technique described is suitable for quantification of tremor intensity in rats and for testing drug interactions on physostigmine-induced tremor.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791238     DOI: 10.1007/BF00427110

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

1.  A simple method for quantifying tremor in rodents.

Authors:  G Remington; H Anisman
Journal:  Pharmacol Biochem Behav       Date:  1976-06       Impact factor: 3.533

2.  Antimuscarinic drugs--effect on brain acetylcholine and tremors in rats.

Authors:  V H Sethy; M H Van Woert
Journal:  Biochem Pharmacol       Date:  1973-11-01       Impact factor: 5.858

3.  Evaluation of anti-tremor drugs in tremor-induced rodents.

Authors:  H C Yen; C A Day
Journal:  Arch Int Pharmacodyn Ther       Date:  1965-05

4.  A simple method for recording tremors in small animals.

Authors:  R E Dill; H L Dorman; W M Nickey
Journal:  J Appl Physiol       Date:  1968-04       Impact factor: 3.531

5.  Chemical and biological studies of tremorine, oxotremorine and oxotremorine antagonists.

Authors:  B Karlén
Journal:  Acta Pharm Suec       Date:  1970-06

6.  On the interaction of drugs with the cholinergic nervous system--V. Characterization of some effects induced by physostigmine in mice: in vivo and in vitro studies.

Authors:  S Maayani; Y Egozi; I Pinchasi; M Sokolovsky
Journal:  Biochem Pharmacol       Date:  1978-01-15       Impact factor: 5.858

7.  Modification of the tremorigenic activity of physostigmine.

Authors:  L M Ambrani; M H Van Woert
Journal:  Br J Pharmacol       Date:  1972-10       Impact factor: 8.739

8.  The analysis of drug-induced tremor in mice.

Authors:  A AHMED; N R TAYLOR
Journal:  Br J Pharmacol Chemother       Date:  1959-09

9.  The relationship between tremor and change in brain acetylcholine concentration produced by injection of tremorine or oxotremorine in the rat.

Authors:  B Cox; D Potkonjak
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

  9 in total
  3 in total

1.  The time and space machine: continuous measurement of drug-induced behavior patterns in the rat.

Authors:  D M Stoff; K Stauderman; R J Wyatt
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

2.  Drugs for Parkinson's disease reduce tremor induced by physostigmine.

Authors:  P Gothóni; M Lehtinen; M Fincke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-07       Impact factor: 3.000

3.  Driving ability in patients with dizziness: a systematic review.

Authors:  Marie-Hélène Uwents; Cathérine Jorissen; Angelique Van Ombergen; Bieke Dobbels; Raymond van de Berg; Sebastien Janssens de Varebeke; Marc Lammers; Veerle Ross; Olivier Vanderveken; Tom Brijs; Vincent Van Rompaey
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-31       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.